These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3991744)

  • 1. In vitro sensitivity of neuroblastoma cells to antineoplastic drugs by short-term test.
    Rosanda C; Garaventa A; Pasino M; Strigini P; De Bernardi B
    Prog Clin Biol Res; 1985; 175():515-23. PubMed ID: 3991744
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible relationship of chromosome abnormalities and gene amplification with effects of chemotherapy: a neuroblastoma xenograft study.
    Tsuchida Y; Kaneko Y; Kanda N; Makino S; Utakoji T; Saito S
    Prog Clin Biol Res; 1985; 175():171-80. PubMed ID: 3991730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the disposition of (-)-delta 9-tetrahydrocannabinol in neuroblastoma and glioma cells in tissue culture: relation cellular impairment.
    End DW; Thoursen K; Dewey WL; Carchman RA
    Mol Pharmacol; 1977 Sep; 13(5):864-71. PubMed ID: 895721
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs.
    Drewinko B; Barlogie B
    Cancer Treat Rep; 1976 Dec; 60(12):1707-17. PubMed ID: 1026329
    [No Abstract]   [Full Text] [Related]  

  • 5. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
    Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cell proliferation kinetics and cytostatica - test for sensitivity of neuroblastomas, recurrent tumours and tumour metastases (author's transl)].
    Willnow U
    Z Kinderchir; 1981 Jun; 33(2):110-21. PubMed ID: 7282079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uptake of radioactive precursors for the evaluation of sensitivity of anticancer drugs against cancer cells].
    Ichihashi H; Kondo T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1130-8. PubMed ID: 6471419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro chemosensitivity test of human solid cancer: 3H-thymidine uptake inhibition test].
    Hanatani Y; Kubota T; Ishibiki K; Abe O
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1123-9. PubMed ID: 6471418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neuroblastoma lines respond differently to diverse differentiation-inducing agents.
    Spengler BA; Domènech C; Porubcin M; Biedler JL
    Prog Clin Biol Res; 1994; 385():261-7. PubMed ID: 7972218
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of prostaglandin A2 on the proliferation and morphologic differentiation of murine neuroblastoma cell line].
    Adolphe M; Giroud JP; Fontagne J; Lechat P; Timsit J
    C R Seances Soc Biol Fil; 1974; 168(6-7):694-8. PubMed ID: 4282032
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
    Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
    Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polyprenoic acid (E5166) on a human neuroblastoma cell line in culture.
    Hasegawa T
    Acta Vitaminol Enzymol; 1984; 6(2):109-15. PubMed ID: 6496254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
    Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
    Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A; Zintl F
    Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anti-proliferation/cytotoxic activity of sixty natural products on the human SH-SY5Y neuroblastoma cells with specific reference to dibenzyl trisulphide.
    Williams LA; Rösner H; Möller W; Conrad J; Nkurunziza JP; Kraus W
    West Indian Med J; 2004 Sep; 53(4):208-19. PubMed ID: 15622673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
    Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.